From USCOM Website: Posted 4 days...

From USCOM Website: Posted 4 days ago
https://uscom.com.au/news/

"USCOM 1A Maternal Hemodynamics - New Publications
Five new global publications in maternal-fetal medicine, support USCOM 1A as the world leader for screening and diagnosis of maternal hypertension. The USCOM 1A will identify the haemodynamic changes of pre-eclampsia at 5-11 weeks allowing for immediate treatment rather than waiting for a routine 18-20 week blood pressure scan when the dangerous changes of hypertension are established.

Hypertension complicates approximately 10% of all pregnancies world wide, and is one of the leading causes of mortality and morbidity for mother and child. USCOM 1A high technology evaluation early in pregnancy can change outcomes of mothers and children and makes first trimester USCOM 1A scanning a new standard of care."

Hi all,
This is a really important field with a lot happening. There is a significant role for Uscom 1A models to play, and it is the device of choice. The 5 listed papers have all been using it to explore their fields of interest.
The company has been aware of the importance of this work and at the moment has new designs in progress that will streamline clinical usage.

For those that do not really understand the Company:
This company has developed and established its world-wide presence by continually reinvesting its profits in steady background growth. It has minimized historic capital raises by disciplined capital management. In this development phase, it budgets and reinvests as much as possible of its earnings in building its marketing and production facilities. Right now it is investing the funds from its recent CR plus any current earnings in major marketing and manufacturing innovations. It has a tight shareholding and NO debt.

Nothing happening - I hear? ... Say NO to Navel Gazing! <grin>

Great investing to all !